Michael Graves is Interim Executive Chair & PEO of EAGLE PHARMACEUTICALS, INC.. Currently has a direct ownership of 10,360 shares of EGRX, which is worth approximately $44,030. The most recent transaction as insider was on Oct 27, 2023, when has been sold 9,360 shares (Common Stock) at a price of $4.94 per share, resulting in proceeds of $46,238. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4K
0% 3M change
n/a 12M change
Total Value Held $44,030

Michael Graves Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 27 2023
BUY
Exercise of conversion of derivative security
$46,238 $4.94 p/Share
9,360 Added 47.46%
10,360 Common Stock
MG

Michael Graves

Interim Executive Chair & PEO
Woodcliff Lake, NJ

Track Institutional and Insider Activities on EGRX

Follow EAGLE PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EGRX shares.

Notify only if

Insider Trading

Get notified when an Eagle Pharmaceuticals, Inc. insider buys or sells EGRX shares.

Notify only if

News

Receive news related to EAGLE PHARMACEUTICALS, INC.

Track Activities on EGRX